Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma

Table 4 Laboratory findings during treatment (case 2)

	Baseline	Week 1	Week 2	Week 4	Week 6	Week 12 (ETR)	Week 12 post therapy (SVR-12)	Week 24 post therapy (SVR-24)
Hgb (g/L)	132	130	115	99	104	103	131	125
WBC (G/L)	5.7	6.4	8.8	5.1	4.5	6.2	6.7	8.1
PLT (G/L)	183	166	304	320	278	308	168	182
Tbil/Dbil (μmol/L)	7/3.6	19/13	24/13	16/10	9/4	34/23	5.2/2.3	6.4/2.6
ALT (U/L)	99	61	53	265	510	45	14	16
PT (s)	13.5	13.7	13.1	15.6	16.3	13.4	14.7	14.4
Alb (g/L)	42	40	49	45	42	43	47	47
HCV RNA (IU/mL)	1799000		UND	UND		UND	UND	UND
FIBROMAXTM	A3/F4					A3/F4
TBA (μmol/L)	4.5					19	5.2